Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
Adil Farooq Wali, Sirajunisa Talath, Rasha Babiker, Mohamed El-Tanani, Imran Rashid Rangraze, Walaa Ibraheem, Yusra Al Aldhaheri, Shakta Mani Satyam, Yahia El-Tanani
TL;DR
Natural products may offer safer and more effective lung cancer treatments by targeting multiple kinases involved in tumor growth and resistance.
Contribution
This review highlights the potential of natural kinase inhibitors as multi-targeted, less toxic alternatives to synthetic drugs in lung cancer therapy.
Findings
Natural kinase inhibitors like curcumin and resveratrol modulate key cancer pathways such as EGFR and MAPK.
Preclinical and emerging clinical evidence supports the use of natural products as adjuncts or alternatives to conventional therapies.
Challenges include poor solubility and limited clinical validation, requiring formulation optimization and large-scale trials.
Abstract
Lung cancer remains a leading cause of cancer mortality worldwide, with current treatments often limited by toxicity and resistance. Dysregulated kinase signaling particularly involving EGFR, PI3K/AKT/mTOR, MAPK, and ALK pathways drives tumor growth, survival, and metastasis. While synthetic kinase inhibitors have improved outcomes, their use is constrained by adverse effects and acquired resistance. Natural kinase inhibitors (NKIs) derived from plants, marine organisms, and microorganisms offer a promising alternative due to their multi-targeted action, lower toxicity, and potential to overcome resistance. This review aims to evaluate the molecular mechanisms, therapeutic potential, and clinical relevance of NKIs in lung cancer management. Key compounds such as curcumin, resveratrol, quercetin, genistein, and epigallocatechin gallate inhibit critical kinases, modulating pathways that…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14
Figure 15
Figure 16
Figure 17
Figure 18
Figure 19
Figure 20
Figure 21
Figure 22
Figure 23
Figure 24
Figure 25
Figure 26
Figure 27
Figure 28
Figure 29
Figure 30
Figure 31
Figure 32
Figure 33
Figure 34
Figure 35
Figure 36
Figure 37
Figure 38
Figure 39
Figure 40
Figure 41
Figure 42
Figure 43
Figure 44
Figure 45
Figure 46
Figure 47
Figure 48
Figure 49
Figure 50Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTannin, Tannase and Anticancer Activities · Curcumin's Biomedical Applications · Biological Research and Disease Studies